Don't forget this little piece of info Keith put out also that...

Don't forget this little piece of info Keith put out also that leaves the door open:

"Unilife has not provided a list of its existing clients, but it has indicated that at least one customization agreement involves multiple products. Then, too, the commercial supply agreements with existing clients may well be expanded beyond the initial number of drugs in the contracts"

So one of these 15 customer programs, 4 of which we know the names of as they are now supply agreements (2 x Sanofi, 1 x Hikma & 1 x Medimmune) and the 5th supply agreement just came through for Depot-ject (unnamed), one of these unknown programs includes multiple products in the customisation process they have been in for a fair while now!

When one thinks of the likes of Eylea, Alirocumab & Dupilumab with Regeneron it could help fit in with the above statement and need for multiple products, if Unilife were to sign supply agreements with Regeneron it would be incremental business for them and obviously with Regeneron as Sanofi's partner one would think they (UNS) are a pretty good chance, in a good position, to get the business!!